Trial data released by Merck & Co. at a Paris medical conference purports to show that a vaccine against the human papilloma virus, strains of which can cause cervical cancer, is effective in women out of their teen years. The report is welcome news to some, who feared a debate about the ethics of vaccinating girls who have not reached the age of consent against a sexually transmitted disease.

Related Summaries